Atorvastatin Calcium
Product Images NDC 66116-498

5 FDA label images from Medvantx, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 66116-498). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medvantx, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical-structure (A0bd00e9 9813 4ea7 B640 1eb59202751b 01)

Chemical-structure (A0bd00e9 9813 4ea7 B640 1eb59202751b 01)
Chemical structure diagram of atorvastatin calcium, illustrating the molecular composition as submitted in the product labeling for MedVantx, Inc.'s ATORVASTATIN CALCIUM (NDC 66116-498). The diagram shows the arrangement of atoms, including calcium ions, consistent with the atorvastatin calcium compound.*
FDA Label Image

Figure-01 (A0bd00e9 9813 4ea7 B640 1eb59202751b 02)

Figure-01 (A0bd00e9 9813 4ea7 B640 1eb59202751b 02)
A line graph depicting cumulative incidence (%) over time (years) comparing Atorvastatin and Placebo groups. The solid line represents Atorvastatin, and the dashed line represents Placebo, showing lower cumulative incidence for Atorvastatin across approximately 3.5 years. The chart includes a hazard ratio (HR=0.64) with confidence intervals and a p-value indicating statistical significance.*
FDA Label Image

Figure-02 (A0bd00e9 9813 4ea7 B640 1eb59202751b 03)

Figure-02 (A0bd00e9 9813 4ea7 B640 1eb59202751b 03)
A line graph comparing the cumulative hazard percentage over a four-year period for placebo versus atorvastatin. The x-axis represents time in years to first primary endpoint, and the y-axis shows cumulative hazard percentage. The graph includes a hazard ratio (HR) of 0.63 with confidence intervals and a p-value indicating statistical significance.*
FDA Label Image

Figure-03 (A0bd00e9 9813 4ea7 B640 1eb59202751b 04)

Figure-03 (A0bd00e9 9813 4ea7 B640 1eb59202751b 04)
A line graph showing the time to first major cardiovascular endpoint over five years for Atorvastatin 10 mg and 80 mg. The x-axis represents years, and the y-axis represents the percentage of subjects experiencing the event. The graph includes a hazard ratio (HR) of 0.78 with confidence intervals and a p-value.*
FDA Label Image

Atorvastatin 20mg Tablets #30 (A0bd00e9 9813 4ea7 B640 1eb59202751b 05)

Atorvastatin 20mg Tablets #30 (A0bd00e9 9813 4ea7 B640 1eb59202751b 05)
The label for Atorvastatin Calcium Tablets, 20 mg, containing 30 tablets, from MedStart CONNECT, distributed by MedVantx, Inc. It includes dosage instructions (blanks for number of tablets, times daily, and days), storage conditions, a note that it is Rx only and a sample not for sale, as well as contact information for free shipping and home delivery.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.